Literature DB >> 23543973

Plasmablastic lymphoma following transplantation.

Michael J Van Vrancken1, Latoya Keglovits, John Krause.   

Abstract

Posttransplant lymphoproliferative disorder is a serious complication following solid organ as well as hematopoietic stem cell transplantation due to prolonged immunosuppressive therapy. Plasmablastic lymphoma, although classically associated with HIV infection, has since been described in transplant patients as a variant of posttransplant lymphoproliferative disorder with varying clinical presentations. Here we add two additional cases to the literature: one following lung transplantation and one following pancreatic transplantation. In addition, the demographic, therapeutic, and immunophenotypic characteristics from prior reported cases are summarized.

Entities:  

Year:  2013        PMID: 23543973      PMCID: PMC3603732          DOI: 10.1080/08998280.2013.11928941

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  26 in total

1.  Post-transplant plasmablastic lymphoma of the skin.

Authors:  I Nicol; T Boye; F Carsuzaa; L Feier; A M Collet Villette; L Xerri; J J Grob; M A Richard
Journal:  Br J Dermatol       Date:  2003-10       Impact factor: 9.302

2.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

Authors:  A Gustafsson; V Levitsky; J Z Zou; T Frisan; T Dalianis; P Ljungman; O Ringden; J Winiarski; I Ernberg; M G Masucci
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

Review 3.  Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

Authors:  C V Paya; J J Fung; M A Nalesnik; E Kieff; M Green; G Gores; T M Habermann; P H Wiesner; J L Swinnen; E S Woodle; J S Bromberg
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

4.  Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma.

Authors:  Ok-Jun Lee; Kyoung-Won Kim; Geon Kook Lee
Journal:  J Oral Pathol Med       Date:  2006-07       Impact factor: 4.253

5.  Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection.

Authors:  A Buda; A Caforio; F Calabrese; S Fagiuoli; S Pevere; U Livi; R Naccarato; P Burra
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

6.  Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.

Authors:  R Reshef; M R Luskin; M Kamoun; S Vardhanabhuti; J E Tomaszewski; E A Stadtmauer; D L Porter; D F Heitjan; De E Tsai
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

7.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

8.  Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.

Authors:  R Mañez; M C Breinig; P Linden; J Wilson; J Torre-Cisneros; S Kusne; S Dummer; M Ho
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

9.  Posttransplant lymphoproliferative disease in liver transplant patients.

Authors:  Christina Hartmann; Marcus Schuchmann; Tim Zimmermann
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

10.  Malignant neoplasms following bone marrow transplantation.

Authors:  S Bhatia; N K Ramsay; M Steinbuch; K E Dusenbery; R S Shapiro; D J Weisdorf; L L Robison; J S Miller; J P Neglia
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  4 in total

Review 1.  Plasmablastic lymphoma following combination treatment with fludarabine and rituximab for nongastric mucosa-associated lymphoid tissue lymphoma: a case report and review of literature.

Authors:  Jia-Zhu Wu; Ke Min; Lei Fan; Li Wang; Ji Xu; Jian-Yong Li; Wei Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Plasmablastic Lymphoma Found on Autopsy in a Post-Transplant Patient.

Authors:  Syed H Abbas; Geetika Goyal; Mohammad A Noory; Abraham Loo
Journal:  Cureus       Date:  2020-05-14

3.  [Clinical characteristics and survival analysis of eight cases HIV-negative plasmablastic lymphoma].

Authors:  X Han; L X Hu; M Q Ouyang; M H Duan; D B Zhou
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14

4.  Plasmablastic Lymphoma Causing Adult Intussusception After Cardiac Transplantation.

Authors:  Jeffrey Silverstein; Helen Liu; David Shin; David Berler
Journal:  CRSLS       Date:  2021-11-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.